Black Diamond Therapeutics Inc
NASDAQ:BDTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
Dynamatic Technologies Ltd
NSE:DYNAMATECH
|
IN |
|
Credito Emiliano SpA
MIL:CE
|
IT |
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
Corporate Travel Management Ltd
ASX:CTD
|
AU |
|
G
|
General Mills Inc
DUS:GRM
|
US |
|
Voltas Ltd
NSE:VOLTAS
|
IN |
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
US |
Wall St Price Targets
BDTX Price Targets Summary
Black Diamond Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for BDTX is 10.05 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BDTX's stock price target?
Price Target
10.05
USD
According to Wall Street analysts, the average 1-year price target for BDTX is 10.05 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Black Diamond Therapeutics Inc?
Projected CAGR
32%
The compound annual growth rate for Revenue over the next 8 years is 32%.
What is the Operating Income forecast for Black Diamond Therapeutics Inc?
Projected CAGR
40%
The compound annual growth rate for Operating Income over the next 8 years is 40%.
What is the Net Income forecast for Black Diamond Therapeutics Inc?
Projected CAGR
22%
The compound annual growth rate for Net Income over the next 8 years is 22%.
